- Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
- Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate
- VA STAND Act introduced in the United States Senate
- Lifeward Announces Reverse Share Split
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
- ReWalk Robotics Expands Direct Sales Coverage to Canada
More ▼
Key statistics
On Wednesday, ReWalk Robotics Ltd (LFWD:NAQ) closed at 5.00, 28.21% above the 52 week low of 3.90 set on Mar 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.00 |
---|---|
High | 5.14 |
Low | 4.86 |
Bid | 4.79 |
Offer | 5.00 |
Previous close | 4.99 |
Average volume | 101.53k |
---|---|
Shares outstanding | 8.50m |
Free float | 8.33m |
P/E (TTM) | -- |
Market cap | 42.40m USD |
EPS (TTM) | -2.59 USD |
Data delayed at least 15 minutes, as of Apr 17 2024 21:00 BST.
More ▼